Spruce Biosciences Inc (SPRB) Annual Balance Sheets

Annual · GAAP · USD millions
Access SPRB quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Spruce Biosciences Inc.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent48.91
Short-term Investments, Total0.00
Cash & Short-term Investments48.00
Other Current Assets2.85
Prepaid Expense, Current AS0.35
Total Current Assets52.11
Long-term investments0.00
Other Assets, Noncurrent0.91
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset-
Total Assets53.02
Liabilities
Accounts Payable, Current AC0.94
Accrued Liabilities, Current AC0.00
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.00
Total Current Liabilities10.09
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Accrued Expenses And Other Current Liabilities9.14
Operating Lease Liability Noncurrent0.42
Total Liabilities10.51
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock331.75
Retained Earnings / Accumulated Deficit-289.23
Other Equity0.00
Common Stockholder's Equity42.52
Total Stockholder's Equity42.52
Liabilities & Stockholder's Equity53.02
4 historic quarters locked

Sign in to unlock the full Spruce Biosciences Inc balance sheet history.

About Spruce Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-097558

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.